Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00185640
Status:
COMPLETED
Last Update Posted:
2021-06-29
First Post:
2005-09-12
Brief Title:
Allogeneic Transplantation Using Total Lymphoid Irradiation TLI and Anti-Thymocyte Globulin ATG for Older Patients With Hematologic Malignancies
Sponsor:
Stanford University
Organization:
Stanford University
Study Overview
Official Title:
Allogeneic Hematopoietic Cell Transplantation Using a Non-Myeloablative Preparative Regimen of Total Lymphoid Irradiation and Anti-Thymocyte Globulin for Older Patients With Hematologic Malignancies
Status:
COMPLETED
Status Verified Date:
2021-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To measure how frequently and to what degree a complication of transplant cell acute graft versus host disease GvHD occurs
Detailed Description:
This study evaluated whether TLI-ATG conditioning followed by allogeneic hematpoietic cell transplant HCT which has provided excellent overall survival for patients with relapsed lymphoma after failed autologous HCT provides a similar benefit in the setting of elderly patients with hematologic malignancies
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 78998 | OTHER | None | None |
| BMT153 | OTHER | OnCore | None |